A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults with Eosinophilic Esophagitis

Recruiting

Phase 2

NSI-8226A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults with Eosinophilic Esophagitis

Sponsor:

Uniquity One (UNI)

Code:

NCT06598462

Conditions

Eosinophilic Esophagitis (EoE)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Solrikitug Low Dose

Solrikitug Mid Dose

Solrikitug High Dose

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-02. This information was provided to ClinicalTrials.gov by Uniquity One (UNI) on 2024-11-12.